DYNAPEN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dynapen, and what generic alternatives are available?
Dynapen is a drug marketed by Apothecon and is included in one NDA.
The generic ingredient in DYNAPEN is dicloxacillin sodium. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dynapen
A generic version of DYNAPEN was approved as dicloxacillin sodium by TEVA on June 3rd, 1982.
Summary for DYNAPEN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 36 |
Patent Applications: | 4,605 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DYNAPEN at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for DYNAPEN
US Patents and Regulatory Information for DYNAPEN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Apothecon | DYNAPEN | dicloxacillin sodium | FOR SUSPENSION;ORAL | 050337-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |